OBJECTIVE: The purpose of this study was to determine if antioxidant supplementation during pregnancy reduces the incidence of premature rupture of the membranes (PROM). STUDY DESIGN: A placebo-controlled, double-blind trial was conducted. PROM and preterm PROM (PPROM) were planned secondary outcomes of the trial. Women between 12(0/7) and 19(6/7) weeks of gestation and diagnosed to have chronic hypertension or a prior history of preeclampsia were randomized to daily treatment with both vitamin C (1000 mg) and E (400 IU) or placebo. RESULTS: Outcome data for PROM were available for 697 of 739 patients. The rates of PROM (37/349 [10.6%] vs 19/348 [5.5%]; adjusted risk ratio [RR] 1.89 [95.42% CI, 1.11-3.23]; P = .015), and PPROM (16/349 [4.6%] vs 6/348 [1.7%]; RR 2.68 [1.07-6.71]; P = .025) were increased in the antioxidant group. CONCLUSION: Contrary to expectations, vitamins C and E supplementation in this dose combination may be associated with an increased risk of PROM and PPROM.
RCT Entities:
OBJECTIVE: The purpose of this study was to determine if antioxidant supplementation during pregnancy reduces the incidence of premature rupture of the membranes (PROM). STUDY DESIGN: A placebo-controlled, double-blind trial was conducted. PROM and preterm PROM (PPROM) were planned secondary outcomes of the trial. Women between 12(0/7) and 19(6/7) weeks of gestation and diagnosed to have chronic hypertension or a prior history of preeclampsia were randomized to daily treatment with both vitamin C (1000 mg) and E (400 IU) or placebo. RESULTS: Outcome data for PROM were available for 697 of 739 patients. The rates of PROM (37/349 [10.6%] vs 19/348 [5.5%]; adjusted risk ratio [RR] 1.89 [95.42% CI, 1.11-3.23]; P = .015), and PPROM (16/349 [4.6%] vs 6/348 [1.7%]; RR 2.68 [1.07-6.71]; P = .025) were increased in the antioxidant group. CONCLUSION: Contrary to expectations, vitamins C and E supplementation in this dose combination may be associated with an increased risk of PROM and PPROM.
Authors: L C Chappell; P T Seed; A L Briley; F J Kelly; R Lee; B J Hunt; K Parmar; S J Bewley; A H Shennan; P J Steer; L Poston Journal: Lancet Date: 1999-09-04 Impact factor: 79.321
Authors: Anna Maria Siega-Riz; Joanne H E Promislow; David A Savitz; John M Thorp; Thad McDonald Journal: Am J Obstet Gynecol Date: 2003-08 Impact factor: 8.661
Authors: Joseph A Spinnato; Salvio Freire; Joao Luiz Pinto E Silva; Marilza Vieira Cunha Rudge; Sérgio Martins-Costa; Matthew A Koch; Norman Goco; Cleide de Barros Santos; Jose Guilherme Cecatti; Roberto Costa; José Geraldo Ramos; Nancy Moss; Baha M Sibai Journal: Obstet Gynecol Date: 2007-12 Impact factor: 7.661
Authors: Sophia M R Lannon; Jeroen P Vanderhoeven; David A Eschenbach; Michael G Gravett; Kristina M Adams Waldorf Journal: Reprod Sci Date: 2014-05-19 Impact factor: 3.060
Authors: John C Hauth; Rebecca G Clifton; James M Roberts; Catherine Y Spong; Leslie Myatt; Kenneth J Leveno; Gail D Pearson; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland B Anderson Journal: Obstet Gynecol Date: 2010-09 Impact factor: 7.661
Authors: Brian M Mercer; Adli Abdelrahim; Robert M Moore; Jillian Novak; Deepak Kumar; Joseph M Mansour; Marina Perez-Fournier; Cynthia J Milluzzi; John J Moore Journal: Reprod Sci Date: 2010-07 Impact factor: 3.060
Authors: R M Moore; F Schatz; D Kumar; B M Mercer; A Abdelrahim; N Rangaswamy; C Bartel; J M Mansour; C J Lockwood; J J Moore Journal: Placenta Date: 2010-08-14 Impact factor: 3.481